Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Tau-based therapies in neurodegeneration: opportunities and challenges
Chuanzhou Li, Jürgen Götz
Nature Reviews Drug Discovery (2017) Vol. 16, Iss. 12, pp. 863-883
Closed Access | Times Cited: 225

Showing 1-25 of 225 citing articles:

Alzheimer’s disease hypothesis and related therapies
Xiaoguang Du, Xinyi Wang, Meiyu Geng
Translational Neurodegeneration (2018) Vol. 7, Iss. 1
Open Access | Times Cited: 537
Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing
Barry Boland, Wen H. Yu, Olga Corti, et al.
Nature Reviews Drug Discovery (2018) Vol. 17, Iss. 9, pp. 660-688
Open Access | Times Cited: 470
The blood-brain barrier: Physiology and strategies for drug delivery
Rucha Pandit, Liyu Chen, Jürgen Götz
Advanced Drug Delivery Reviews (2019) Vol. 165-166, pp. 1-14
Closed Access | Times Cited: 455
Rodent models for Alzheimer disease
Jürgen Götz, Liviu‐Gabriel Bodea, Michel Goedert
Nature reviews. Neuroscience (2018) Vol. 19, Iss. 10, pp. 583-598
Closed Access | Times Cited: 303
Discovery of a Keap1-dependent peptide PROTAC to knockdown Tau by ubiquitination-proteasome degradation pathway
Mengchen Lu, Tian Liu, Qiong Jiao, et al.
European Journal of Medicinal Chemistry (2018) Vol. 146, pp. 251-259
Closed Access | Times Cited: 250
A walk through tau therapeutic strategies
Santosh Jadhav, Jesús Ávila, Michael Schöll, et al.
Acta Neuropathologica Communications (2019) Vol. 7, Iss. 1
Open Access | Times Cited: 248
BACE1 inhibitors: Current status and future directions in treating Alzheimer's disease
Nour M. Moussa‐Pacha, Shifaa M. Abdin, Hany A. Omar, et al.
Medicinal Research Reviews (2019) Vol. 40, Iss. 1, pp. 339-384
Open Access | Times Cited: 246
Molecular Pathogenesis of the Tauopathies
Jürgen Götz, Glenda M. Halliday, Rebecca M. Nisbet
Annual Review of Pathology Mechanisms of Disease (2018) Vol. 14, Iss. 1, pp. 239-261
Closed Access | Times Cited: 224
Lysine/RNA-interactions drive and regulate biomolecular condensation
Tina Ukmar, Saskia Hutten, Matthew P. Grieshop, et al.
Nature Communications (2019) Vol. 10, Iss. 1
Open Access | Times Cited: 217
Disease‐associated tau impairs mitophagy by inhibiting Parkin translocation to mitochondria
Nadia Cummins, Andrea Tweedie, Steven Zuryn, et al.
The EMBO Journal (2018) Vol. 38, Iss. 3
Open Access | Times Cited: 214
Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies
Yu Chen, Amy K.Y. Fu, Nancy Y. Ip
Pharmacology & Therapeutics (2018) Vol. 195, pp. 186-198
Closed Access | Times Cited: 183
Nrf2: a dark horse in Alzheimer's disease treatment
Alsiddig Osama, Junmin Zhang, Juan Yao, et al.
Ageing Research Reviews (2020) Vol. 64, pp. 101206-101206
Closed Access | Times Cited: 183
Radiopharmaceuticals for PET and SPECT Imaging: A Literature Review over the Last Decade
George Crișan, Nastasia Sanda Moldovean-Cioroianu, Diana-Gabriela Timaru, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 9, pp. 5023-5023
Open Access | Times Cited: 181
Flavonoids as Therapeutic Agents in Alzheimer’s and Parkinson’s Diseases: A Systematic Review of Preclinical Evidences
Roxana Braga de Andrade Teles, Tâmara Coimbra Diniz, Tiago Coimbra Costa Pinto, et al.
Oxidative Medicine and Cellular Longevity (2018) Vol. 2018, Iss. 1
Open Access | Times Cited: 176
Rutin prevents tau pathology and neuroinflammation in a mouse model of Alzheimer’s disease
Xiaoying Sun, Lingjie Li, Quan-xiu Dong, et al.
Journal of Neuroinflammation (2021) Vol. 18, Iss. 1
Open Access | Times Cited: 173
Dural lymphatics regulate clearance of extracellular tau from the CNS
Tirth K. Patel, LeMoyne Habimana-Griffin, Xuefeng Gao, et al.
Molecular Neurodegeneration (2019) Vol. 14, Iss. 1
Open Access | Times Cited: 160
Tau and neuroinflammation in Alzheimer’s disease: interplay mechanisms and clinical translation
Yijun Chen, Yang Yu
Journal of Neuroinflammation (2023) Vol. 20, Iss. 1
Open Access | Times Cited: 153
Endophenotype-based in silico network medicine discovery combined with insurance record data mining identifies sildenafil as a candidate drug for Alzheimer’s disease
Jiansong Fang, Pengyue Zhang, Yadi Zhou, et al.
Nature Aging (2021) Vol. 1, Iss. 12, pp. 1175-1188
Open Access | Times Cited: 145
Gene-based therapies for neurodegenerative diseases
Jichao Sun, Subhojit Roy
Nature Neuroscience (2021) Vol. 24, Iss. 3, pp. 297-311
Open Access | Times Cited: 134
A Perspective on Nrf2 Signaling Pathway for Neuroinflammation: A Potential Therapeutic Target in Alzheimer's and Parkinson's Diseases
Sarmistha Saha, Brigitta Buttari, Elisabetta Profumo, et al.
Frontiers in Cellular Neuroscience (2022) Vol. 15
Open Access | Times Cited: 131
Protein posttranslational modifications in health and diseases: Functions, regulatory mechanisms, and therapeutic implications
Qian Zhong, Xina Xiao, Yijie Qiu, et al.
MedComm (2023) Vol. 4, Iss. 3
Open Access | Times Cited: 119
Microglia and Alzheimer’s Disease
Stefania Merighi, Manuela Nigro, Alessia Travagli, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12990-12990
Open Access | Times Cited: 114
Electroacupuncture ameliorates beta-amyloid pathology and cognitive impairment in Alzheimer disease via a novel mechanism involving activation of TFEB (transcription factor EB)
Xiaoyan Zheng, Wenjia Lin, Yimin Jiang, et al.
Autophagy (2021) Vol. 17, Iss. 11, pp. 3833-3847
Open Access | Times Cited: 106
TRIM11 protects against tauopathies and is down-regulated in Alzheimer’s disease
Z. Zhang, Dilshan S. Harischandra, Ruifang Wang, et al.
Science (2023) Vol. 381, Iss. 6656
Open Access | Times Cited: 56
Customized Intranasal Hydrogel Delivering Methylene Blue Ameliorates Cognitive Dysfunction against Alzheimer's Disease
Yujing Liu, Yun Tan, Guopan Cheng, et al.
Advanced Materials (2024) Vol. 36, Iss. 19
Closed Access | Times Cited: 34
Page 1 - Next Page

Scroll to top